Generic name: umeclidinium [ ue-ME-kli-DIN-ee-um ]
Drug class: Anticholinergic bronchodilators

Medically reviewed by Philip Thornton, DipPharm. Last updated on Aug 23, 2023.

What is Incruse Ellipta?

Incruse Ellipta is an anticholinergic that works by relaxing muscles in the airways to improve breathing.

Incruse Ellipta is used to prevent airflow obstruction and reduce flare-ups in adults with COPD (chronic obstructive pulmonary disease, including bronchitis and emphysema.

Incruse Ellipta is for use only in people with COPD and should not be used to treat asthma.

Warnings

You should not use Incruse Ellipta if you are allergic to umeclidinium or have a severe allergy to milk proteins.

Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack.

Seek medical attention if your breathing problems do not improve, or if your symptoms get worse quickly.

Before taking this medicine

You should not use Incruse Ellipta if you are allergic to umeclidinium, or if you have:

• a severe allergy to milk proteins.

To make sure Incruse Ellipta is safe for you, tell your doctor if you have:

• glaucoma;

• heart disease;

• an enlarged prostate; or

• urination problems.

Tell your doctor if you are pregnant or breastfeeding.

Incruse Ellipta is not approved for use by anyone younger than 18 years old.

How should I use Incruse Ellipta?

Use Incruse Ellipta exactly as it was prescribed for you. Follow all directions on your prescription label and read all medication guides or instruction sheets.

Incruse Ellipta is a powder that comes with a special inhaler device preloaded with blister packs containing measured doses of the medicine. The device opens and loads a blister of powdered medicine each time you use the inhaler. Follow the patient instructions provided with the inhaler device.

The usual dose is 1 inhalation per day. Use the medicine at the same time each day, and not more than once in a 24-hour period.

Incruse Ellipta is not a rescue medicine. It will not work fast enough to treat a bronchospasm attack. Use only a fast acting inhalation medicine for an attack. Tell your doctor if any of your medicines seem to stop working as well in controlling your COPD.

Do not stop using this medicine without your doctor's advice, even if you feel fine.

Do not try to clean or take apart the inhaler device. Always use the new inhaler device provided with your refill.

Store at room temperature away from moisture, heat, and light. Keep the inhaler device in the sealed foil tray until ready to start using it.

Throw the inhaler away 6 weeks after opening, or when the dose indicator shows a zero (whichever comes first).

Dosing information

Usual Adult Dose for Chronic Obstructive Pulmonary Disease -- Maintenance:

1 inhalation (62.5 mcg) orally once a day
Maximum dose: 1 inhalation every 24 hours

Use: Treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema

What happens if I miss a dose?

Use the medicine as soon as you can, but skip the missed dose if it is almost time for your next dose. Do not use two doses at one time. Do not use more than once in a 24-hour period.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

What should I avoid while using Incruse Ellipta?

Do not use a second inhaled bronchodilator that contains aclidinium, arformoterol, indacaterol, olodaterol, salmeterol, tiotropium, or vilanterol.

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Incruse Ellipta side effects

Get emergency medical help if you have signs of an allergic reaction to Incruse Ellipta: hives, rash, severe itching; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

• wheezing, choking, or other breathing problems after using this medicine;

• blurred vision, nausea, vomiting, eye pain or redness, or seeing halos or bright colors around lights; or

• painful or difficult urination, or urinating more often.

Common Incruse Ellipta side effects may include:

• cold symptoms such as stuffy nose, sneezing, sore throat, cough;

• fast or irregular heartbeats;

• bruising, darkened skin;

• mouth pain, tooth pain;

• muscle or joint pain;

• stomach pain; or

• altered sense of taste.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

What other drugs will affect Incruse Ellipta?

Tell your doctor about all your other medicines, especially:

• atropine;

• medicine to treat depression, anxiety, mood disorders, or mental illness;

• cold or allergy medicine (Benadryl and others);

• medicine to treat Parkinson's disease;

• medicine to treat stomach problems, motion sickness, or irritable bowel syndrome;

• medicine to treat overactive bladder; or

• another bronchodilator medication.

This list is not complete. Other drugs may interact with umeclidinium, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Further information

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Incruse Ellipta only for the indication prescribed.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer

Copyright 1996-2024 Cerner Multum, Inc. Version: 4.01.